Glucagon, secreted by pencreatic a-cells, has a similar inhibitory effect on Insulin secretion, and stimutes hepatic glycogenolysis and gluconeogensis very rapidly: hence its use in the treatment of hypoglycemia resulting from exogenously administered insulin.